U.K.-based diagnostic and analytical services company LGC established a genomics division, LGC Genomics. The new business will offer a range of nucleic acid sample extraction services and products along with next-generation sequencing and other genomic services, the firm claims.
Offerings will include the genomics products and services acquired by LGC through its 2005 buy-out of Agowa. These products and services will be rebranded under the LGC Genomics umbrella.
LGC says that establishing a dedicated genomics unit is part of a wider restructuring program designed to expand the firm’s operations. “Under the new brand, LGC Genomics will continue to advance the development and delivery of first-rate genomic services and products,” comments John McQuillian, the new division’s managing director. “Our aim is for LGC Genomics to become Europe’s leading genomics provider through organic growth and selected strategic acquisitions.”